Body,Head,Head Coverage,Standard Confidence,Pca Confidence,Support,Body Size,Pca Body Size,Functional Variable
?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.5,0.5,33,66,66,?a
?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.571429,0.571429,44,77,77,?a
?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.625,0.625,55,88,88,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.333333,0.333333,33,99,99,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.214286,0.214286,33,154,154,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.555556,0.555556,55,99,99,?a
?a  hasGender  Female   ,?a  hasSmokingHabit  FormerSmoker,0.275862,0.5,0.5,88,176,176,?a
?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.294118,0.294118,55,187,187,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.5,0.5,44,88,88,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.333333,0.333333,44,132,132,?a
?a  hasAgeCategory  Old   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.384615,0.384615,55,143,143,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.275862,0.5,0.5,88,176,176,?a
?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.363636,0.363636,44,121,121,?a
?a  hasAgeCategory  Young   ,?a  hasSmokingHabit  FormerSmoker,0.206897,0.375,0.375,66,176,176,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.25,0.25,55,220,220,?a
?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.307692,0.307692,44,143,143,?a
?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.333333,0.333333,33,99,99,?a
?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.241379,0.411765,0.411765,77,187,187,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Young,0.344828,0.588235,0.588235,110,187,187,?a
?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.625,0.625,55,88,88,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.294118,0.294118,55,187,187,?a
?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.375,0.375,33,88,88,?a
?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.344828,0.384615,0.384615,110,286,286,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.241379,0.304348,0.304348,77,253,253,?a
?a  type  Patient   ,?a  hasSmokingHabit  FormerSmoker,0.37931,0.37931,0.37931,121,319,319,?a
?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.344828,0.4,0.4,110,275,275,?a
?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.206897,0.75,0.75,66,88,88,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasAgeCategory  Young,0.310345,0.5625,0.5625,99,176,176,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasAgeCategory  Young,0.241379,0.583333,0.583333,77,132,132,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Young,0.310345,0.642857,0.642857,99,154,154,?a
?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.230769,0.230769,33,143,143,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasAgeCategory  Young,0.344828,0.5,0.5,110,220,220,?a
?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.310345,0.529412,0.529412,99,187,187,?a
?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.241379,0.636364,0.636364,77,121,121,?a
?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.482759,0.56,0.56,154,275,275,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.413793,0.521739,0.521739,132,253,253,?a
?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.275862,0.615385,0.615385,88,143,143,?a
?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.137931,0.444444,0.444444,44,99,99,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.241379,0.875,0.875,77,88,88,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.137931,0.444444,0.444444,44,99,99,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.275862,0.533333,0.533333,88,165,165,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.275862,0.888889,0.888889,88,99,99,?a
?a  hasGender  Male   ,?a  hasAgeCategory  Young,0.172414,0.384615,0.384615,55,143,143,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Young,0.206897,0.545455,0.545455,66,121,121,?a
?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.241379,0.777778,0.777778,77,99,99,?a
?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.448276,0.5,0.5,143,286,286,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.241379,0.583333,0.583333,77,132,132,?a
?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Young,0.241379,0.411765,0.411765,77,187,187,?a
?a  type  Patient   ,?a  hasAgeCategory  Young,0.551724,0.551724,0.551724,176,319,319,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Old,0.172414,0.357143,0.357143,55,154,154,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasAgeCategory  Old,0.172414,0.416667,0.416667,55,132,132,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasAgeCategory  Old,0.241379,0.4375,0.4375,77,176,176,?a
?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.172414,0.555556,0.555556,55,99,99,?a
?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.37931,0.6875,0.6875,121,176,176,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.172414,0.454545,0.454545,55,121,121,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Old,0.241379,0.411765,0.411765,77,187,187,?a
?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.137931,0.363636,0.363636,44,121,121,?a
?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.103448,0.5,0.5,33,66,66,?a
?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Old,0.137931,0.571429,0.571429,44,77,77,?a
?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.448276,0.5,0.5,143,286,286,?a
?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.607143,1,1,187,187,187,?a
?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.392857,1,1,121,121,121,?a
?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.172414,0.625,0.625,55,88,88,?a
?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.464286,1,1,143,143,143,?a
?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.285714,1,1,88,88,88,?a
?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.285714,1,1,88,88,88,?a
?a  hasGender  Male   ,?a  hasAgeCategory  Old,0.275862,0.615385,0.615385,88,143,143,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.172414,0.555556,0.555556,55,99,99,?a
?a  patientDrug  Atezolizumab   ,?a  hasRelapse_Progression  Progression,0.25,1,1,77,77,77,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasRelapse_Progression  Progression,0.035714,1,1,11,11,11,?a
?a  hasStage  IVB   ,?a  hasRelapse_Progression  Progression,0.285714,0.888889,1,88,99,88,?a
?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.178571,0.833333,1,55,66,55,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasAgeCategory  Old,0.344828,0.5,0.5,110,220,220,?a
?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.275862,0.470588,0.470588,88,187,187,?a
?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.172414,0.625,0.625,55,88,88,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Old,0.241379,0.466667,0.466667,77,165,165,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  Progression,0.357143,0.909091,1,110,121,110,?a
?a  hasAgeCategory  Young   ,?a  hasRelapse_Progression  Progression,0.5,0.875,1,154,176,154,?a
?a  hasGender  Female   ,?a  hasAgeCategory  Old,0.172414,0.3125,0.3125,55,176,176,?a
?a  hasStage  IV   ,?a  hasRelapse_Progression  Progression,0.285714,1,1,88,88,88,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.285714,0.888889,1,88,99,88,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.172414,0.416667,0.416667,55,132,132,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.214286,0.75,1,66,88,66,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.357143,0.833333,1,110,132,110,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasRelapse_Progression  Progression,0.392857,0.916667,0.916667,121,132,132,?a
?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.214286,0.75,0.75,66,88,88,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  Progression,0.464286,0.764706,0.866667,143,187,165,?a
?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.172414,0.384615,0.384615,55,143,143,?a
?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Old,0.37931,0.44,0.44,121,275,275,?a
?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.172414,0.625,0.625,55,88,88,?a
?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.344828,0.588235,0.588235,110,187,187,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old   ,?a  hasRelapse_Progression  Progression,0.392857,0.846154,0.846154,121,143,143,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.25,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasRelapse_Progression  Progression,0.571429,0.8,0.888889,176,220,198,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasRelapse_Progression  Progression,0.464286,0.8125,0.928571,143,176,154,?a
?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.428571,0.923077,0.923077,132,143,143,?a
?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.535714,0.882353,0.882353,165,187,187,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.37931,0.478261,0.478261,121,253,253,?a
?a  type  Patient   ,?a  hasAgeCategory  Old,0.448276,0.448276,0.448276,143,319,319,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasRelapse_Progression  Progression,0.464286,0.866667,0.866667,143,165,165,?a
?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.285714,0.888889,0.888889,88,99,99,?a
?a  hasGender  Female   ,?a  hasRelapse_Progression  Progression,0.464286,0.8125,0.928571,143,176,154,?a
?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.02381,0.428571,0.428571,33,77,77,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.031746,0.5,0.5,44,88,88,?a
?a  hasStage  IV   ,?a  patientDrug  Cisplatin,0.031746,0.5,0.5,44,88,88,?a
?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.039683,0.384615,0.384615,55,143,143,?a
?a  hasStage  IVB   ,?a  patientDrug  Cisplatin,0.02381,0.333333,0.333333,33,99,99,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  Progression,0.392857,0.785714,0.916667,121,154,132,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.75,0.913043,0.913043,231,253,253,?a
?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.857143,0.923077,0.923077,264,286,286,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.087302,0.44,0.44,121,275,275,?a
?a  type  Patient   ,?a  hasRelapse_Progression  Progression,0.892857,0.862069,0.925926,275,319,297,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Cisplatin,0.02381,0.176471,0.176471,33,187,187,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.031746,0.444444,0.444444,44,99,99,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.031746,0.5,0.5,44,88,88,?a
?a  hasGender  Female   ,?a  patientDrug  Cisplatin,0.031746,0.25,0.25,44,176,176,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.031746,0.5,0.5,44,88,88,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Cisplatin,0.055556,0.35,0.35,77,220,220,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.031746,0.363636,0.363636,44,121,121,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.047619,0.4,0.4,66,165,165,?a
?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Cisplatin,0.02381,0.214286,0.214286,33,154,154,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.063492,0.470588,0.470588,88,187,187,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.031746,0.444444,0.444444,44,99,99,?a
?a  hasGender  Male   ,?a  patientDrug  Cisplatin,0.055556,0.538462,0.538462,77,143,143,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Cisplatin,0.02381,0.25,0.25,33,132,132,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Cisplatin,0.055556,0.4375,0.4375,77,176,176,?a
?a  hasBiomarker  EGFR_Positive   ,?a  patientDrug  Cisplatin,0.039683,0.3125,0.3125,55,176,176,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Cisplatin,0.047619,0.5,0.5,66,132,132,?a
?a  patientDrug  Gemcitabine   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Cisplatin,0.039683,0.294118,0.294118,55,187,187,?a
?a  type  Patient   ,?a  patientDrug  Cisplatin,0.087302,0.37931,0.37931,121,319,319,?a
?a  patientDrug  Durvalumab   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.545455,0.545455,66,121,121,?a
?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.375,0.375,33,88,88,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.310345,0.75,0.75,99,132,132,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.079365,0.434783,0.434783,110,253,253,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.02381,0.375,0.375,33,88,88,?a
?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.428571,0.428571,33,77,77,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.079365,0.384615,0.384615,110,286,286,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Cisplatin,0.031746,0.307692,0.307692,44,143,143,?a
?a  hasStage  IV   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.375,0.375,33,88,88,?a
?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.615385,0.615385,88,143,143,?a
?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.5,0.5,33,66,66,?a
?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.625,0.625,55,88,88,?a
?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.37931,0.647059,0.647059,121,187,187,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.344828,0.588235,0.588235,110,187,187,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.448276,0.65,0.65,143,220,220,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.375,0.375,66,176,176,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.344828,0.714286,0.714286,110,154,154,?a
?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.310345,0.529412,0.529412,99,187,187,?a
?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.666667,0.666667,66,99,99,?a
?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.666667,0.666667,66,99,99,?a
?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.448276,0.52,0.52,143,275,275,?a
?a  hasAgeCategory  Young   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.5,0.5,88,176,176,?a
?a  hasGender  Female   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.4375,0.4375,77,176,176,?a
?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.5,0.5,44,88,88,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.666667,0.666667,66,99,99,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.454545,0.454545,55,121,121,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.357143,0.357143,55,154,154,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.444444,0.444444,44,99,99,?a
?a  hasAgeCategory  Old   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.538462,0.538462,77,143,143,?a
?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.615385,0.615385,88,143,143,?a
?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.482759,0.538462,0.538462,154,286,286,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  EGFR_Positive,0.113636,0.5,0.5,110,220,220,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Positive,0.090909,0.470588,0.470588,88,187,187,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.5,0.5,66,132,132,?a
?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Positive,0.113636,0.588235,0.588235,110,187,187,?a
?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.517241,0.652174,0.652174,165,253,253,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Positive,0.113636,0.588235,0.588235,110,187,187,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.444444,0.444444,44,99,99,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.5,0.5,44,88,88,?a
?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.444444,0.444444,44,99,99,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.5,0.5,44,88,88,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.4,0.4,66,165,165,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Positive,0.090909,0.666667,0.666667,88,132,132,?a
?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Female,0.206897,0.5,0.5,66,132,132,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Positive,0.090909,0.727273,0.727273,88,121,121,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Positive,0.136364,0.521739,0.521739,132,253,253,?a
?a  type  Patient   ,?a  hasSmokingHabit  CurrentSmoker,0.517241,0.517241,0.517241,165,319,319,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Female,0.344828,0.714286,0.714286,110,154,154,?a
?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.172414,0.625,0.625,55,88,88,?a
?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.37931,0.647059,0.647059,121,187,187,?a
?a  type  Patient   ,?a  hasBiomarker  EGFR_Positive,0.181818,0.551724,0.551724,176,319,319,?a
?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.344828,0.588235,0.588235,110,187,187,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Positive,0.147727,0.5,0.5,143,286,286,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.37931,0.647059,0.647059,121,187,187,?a
?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Positive,0.113636,0.625,0.625,110,176,176,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  EGFR_Positive,0.079545,0.538462,0.538462,77,143,143,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Positive,0.147727,0.52,0.52,143,275,275,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasGender  Female,0.37931,0.55,0.55,121,220,220,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasGender  Female,0.344828,0.625,0.625,110,176,176,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.666667,0.666667,66,99,99,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  EGFR_Positive,0.102273,0.5625,0.5625,99,176,176,?a
?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.137931,0.5,0.5,44,88,88,?a
?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.461538,0.461538,66,143,143,?a
?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.172414,0.625,0.625,55,88,88,?a
?a  hasStage  IVB   ,?a  hasGender  Female,0.206897,0.666667,0.666667,66,99,99,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Female,0.241379,0.466667,0.466667,77,165,165,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Female,0.275862,0.727273,0.727273,88,121,121,?a
?a  hasAgeCategory  Young   ,?a  hasGender  Female,0.37931,0.6875,0.6875,121,176,176,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.172414,0.625,0.625,55,88,88,?a
?a  hasStage  IV   ,?a  hasGender  Female,0.172414,0.625,0.625,55,88,88,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.310345,0.75,0.75,99,132,132,?a
?a  hasAgeCategory  Old   ,?a  hasGender  Female,0.172414,0.384615,0.384615,55,143,143,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.172414,0.555556,0.555556,55,99,99,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.413793,0.521739,0.521739,132,253,253,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.241379,0.777778,0.777778,77,99,99,?a
?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.482759,0.538462,0.538462,154,286,286,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.031746,0.5,0.5,44,88,88,?a
?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.137931,0.363636,0.363636,44,121,121,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Carboplatin,0.055556,0.583333,0.583333,77,132,132,?a
?a  hasRelapse_Progression  Progression   ,?a  hasGender  Female,0.448276,0.52,0.52,143,275,275,?a
?a  patientDrug  Atezolizumab   ,?a  hasGender  Female,0.137931,0.571429,0.571429,44,77,77,?a
?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.275862,0.615385,0.615385,88,143,143,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.039683,0.625,0.625,55,88,88,?a
?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Carboplatin,0.063492,0.571429,0.571429,88,154,154,?a
?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.031746,0.5,0.5,44,88,88,?a
?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.039683,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.087302,0.647059,0.647059,121,187,187,?a
?a  hasBiomarker  EGFR_Positive   ,?a  patientDrug  Carboplatin,0.079365,0.625,0.625,110,176,176,?a
?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.063492,0.615385,0.615385,88,143,143,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Carboplatin,0.111111,0.7,0.7,154,220,220,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Carboplatin,0.087302,0.647059,0.647059,121,187,187,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.047619,0.75,0.75,66,88,88,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.055556,0.777778,0.777778,77,99,99,?a
?a  hasGender  Male   ,?a  patientDrug  Carboplatin,0.055556,0.538462,0.538462,77,143,143,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.047619,0.666667,0.666667,66,99,99,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Carboplatin,0.039683,0.454545,0.454545,55,121,121,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.087302,0.733333,0.733333,121,165,165,?a
?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.047619,0.666667,0.666667,66,99,99,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Carboplatin,0.079365,0.769231,0.769231,110,143,143,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.119048,0.6,0.6,165,275,275,?a
?a  hasGender  Female   ,?a  patientDrug  Carboplatin,0.079365,0.625,0.625,110,176,176,?a
?a  type  Patient   ,?a  hasGender  Female,0.551724,0.551724,0.551724,176,319,319,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Carboplatin,0.055556,0.4375,0.4375,77,176,176,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.126984,0.615385,0.615385,176,286,286,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.031746,0.444444,0.444444,44,99,99,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Pembrolizumab,0.071429,0.75,0.75,99,132,132,?a
?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.039683,0.454545,0.454545,55,121,121,?a
?a  hasBiomarker  EGFR_Positive   ,?a  patientDrug  Pembrolizumab,0.02381,0.1875,0.1875,33,176,176,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.063492,0.666667,0.666667,88,132,132,?a
?a  hasStage  IVA   ,?a  patientDrug  Pembrolizumab,0.031746,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Pembrolizumab,0.063492,0.470588,0.470588,88,187,187,?a
?a  type  Patient   ,?a  patientDrug  Carboplatin,0.134921,0.586207,0.586207,187,319,319,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Pembrolizumab,0.031746,0.5,0.5,44,88,88,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.039683,0.555556,0.555556,55,99,99,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pembrolizumab,0.063492,0.533333,0.533333,88,165,165,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Pembrolizumab,0.063492,0.470588,0.470588,88,187,187,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pembrolizumab,0.103175,0.52,0.52,143,275,275,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.126984,0.695652,0.695652,176,253,253,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pembrolizumab,0.031746,0.363636,0.363636,44,121,121,?a
?a  hasStage  IVB   ,?a  patientDrug  Pembrolizumab,0.031746,0.444444,0.444444,44,99,99,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Pembrolizumab,0.071429,0.45,0.45,99,220,220,?a
?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Pembrolizumab,0.071429,0.642857,0.642857,99,154,154,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.039683,0.555556,0.555556,55,99,99,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Pembrolizumab,0.039683,0.384615,0.384615,55,143,143,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Pembrolizumab,0.063492,0.5,0.5,88,176,176,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.031746,0.444444,0.444444,44,99,99,?a
?a  hasGender  Male   ,?a  patientDrug  Pembrolizumab,0.039683,0.384615,0.384615,55,143,143,?a
?a  hasGender  Female   ,?a  patientDrug  Pembrolizumab,0.063492,0.5,0.5,88,176,176,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.571429,0.571429,88,154,154,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.087302,0.478261,0.478261,121,253,253,?a
?a  type  Patient   ,?a  patientDrug  Pembrolizumab,0.103175,0.448276,0.448276,143,319,319,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.063492,0.470588,0.470588,88,187,187,?a
?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.555556,0.555556,55,99,99,?a
?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.461538,0.461538,66,143,143,?a
?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.375,0.375,66,176,176,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.545455,0.545455,66,121,121,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.411765,0.411765,77,187,187,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.5,0.5,44,88,88,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.103175,0.5,0.5,143,286,286,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  EGFR_Negative,0.113636,0.5,0.5,110,220,220,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pembrolizumab,0.031746,0.333333,0.333333,44,132,132,?a
?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.4375,0.4375,77,176,176,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.411765,0.411765,77,187,187,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.102273,0.529412,0.529412,99,187,187,?a
?a  type  Patient   ,?a  hasBiomarker  EGFR_Negative,0.136364,0.413793,0.413793,132,319,319,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.666667,0.666667,66,99,99,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.333333,0.333333,44,132,132,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.5,0.5,44,88,88,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.136364,0.461538,0.461538,132,286,286,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.125,0.478261,0.478261,121,253,253,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.555556,0.555556,55,99,99,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.039683,0.625,0.625,55,88,88,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.102273,0.6,0.6,99,165,165,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.087302,0.647059,0.647059,121,187,187,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.031746,0.5,0.5,44,88,88,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.384615,0.384615,55,143,143,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.031746,0.444444,0.444444,44,99,99,?a
?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.055556,0.777778,0.777778,77,99,99,?a
?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.039683,0.625,0.625,55,88,88,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.102273,0.692308,0.692308,99,143,143,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Pemetrexed,0.103175,0.65,0.65,143,220,220,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.125,0.44,0.44,121,275,275,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.055556,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.063492,0.615385,0.615385,88,143,143,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.071429,0.6,0.6,99,165,165,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.039683,0.555556,0.555556,55,99,99,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Pemetrexed,0.063492,0.615385,0.615385,88,143,143,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.134921,0.68,0.68,187,275,275,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Pemetrexed,0.055556,0.583333,0.583333,77,132,132,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.119048,0.652174,0.652174,165,253,253,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Pemetrexed,0.071429,0.5625,0.5625,99,176,176,?a
?a  type  Patient   ,?a  patientDrug  Pemetrexed,0.134921,0.586207,0.586207,187,319,319,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.063492,0.666667,0.666667,88,132,132,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.047619,0.75,0.75,66,88,88,?a
?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Pemetrexed,0.087302,0.647059,0.647059,121,187,187,?a
?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.102273,1,1,99,99,99,?a
?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.047619,0.857143,0.857143,66,77,77,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.039683,0.555556,0.555556,55,99,99,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.031746,0.5,0.5,44,88,88,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.079545,0.636364,0.636364,77,121,121,?a
?a  hasBiomarker  EGFR_Positive   ,?a  patientDrug  Pemetrexed,0.079365,0.625,0.625,110,176,176,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.126984,0.615385,0.615385,176,286,286,?a
?a  hasGender  Female   ,?a  patientDrug  Pemetrexed,0.087302,0.6875,0.6875,121,176,176,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ALK_Negative,0.113636,0.833333,0.833333,110,132,132,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasBiomarker  ALK_Negative,0.113636,0.625,0.625,110,176,176,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.147727,0.928571,0.928571,143,154,154,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.181818,0.941176,0.941176,176,187,187,?a
?a  hasGender  Male   ,?a  patientDrug  Pemetrexed,0.047619,0.461538,0.461538,66,143,143,?a
?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Pemetrexed,0.063492,0.571429,0.571429,88,154,154,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.147727,0.764706,0.764706,143,187,187,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.159091,0.823529,0.823529,154,187,187,?a
?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.147727,0.866667,0.866667,143,165,165,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.056818,0.555556,0.555556,55,99,99,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.056818,0.454545,0.454545,55,121,121,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  ALK_Negative,0.113636,0.769231,0.769231,110,143,143,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.113636,0.833333,0.833333,110,132,132,?a
?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.125,0.6875,0.6875,121,176,176,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasBiomarker  ROS1_Negative,0.090909,0.5,0.5,88,176,176,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  ALK_Negative,0.113636,0.625,0.625,110,176,176,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.068182,0.666667,0.666667,66,99,99,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.193182,0.653846,0.653846,187,286,286,?a
?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.102273,0.692308,0.692308,99,143,143,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.068182,0.666667,0.666667,66,99,99,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.102273,0.692308,0.692308,99,143,143,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.045455,0.5,0.5,44,88,88,?a
?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  type  Patient   ,?a  hasBiomarker  ALK_Negative,0.227273,0.689655,0.689655,220,319,319,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ALK_Negative,0.181818,0.64,0.64,176,275,275,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.193182,0.73913,0.73913,187,253,253,?a
?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.444444,0.444444,44,99,99,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.136364,0.857143,0.857143,132,154,154,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ROS1_Negative,0.102273,0.75,0.75,99,132,132,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.666667,0.666667,66,99,99,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.625,0.625,55,88,88,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.090909,0.615385,0.615385,88,143,143,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.125,0.647059,0.647059,121,187,187,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  ROS1_Negative,0.181818,0.8,0.8,176,220,220,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.454545,0.454545,55,121,121,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.125,0.647059,0.647059,121,187,187,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.5,0.5,44,88,88,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.555556,0.555556,55,99,99,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.170455,0.576923,0.576923,165,286,286,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  ROS1_Negative,0.113636,0.625,0.625,110,176,176,?a
?a  hasGender  Male   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.461538,0.461538,66,143,143,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.454545,0.454545,55,121,121,?a
?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.125,0.6875,0.6875,121,176,176,?a
?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.090909,0.888889,0.888889,88,99,99,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.625,0.625,55,88,88,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.090909,0.666667,0.666667,88,132,132,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.113636,0.666667,0.666667,110,165,165,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  ROS1_Negative,0.079545,0.538462,0.538462,77,143,143,?a
?a  type  Patient   ,?a  hasBiomarker  ROS1_Negative,0.193182,0.586207,0.586207,187,319,319,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.147727,0.565217,0.565217,143,253,253,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ROS1_Negative,0.147727,0.52,0.52,143,275,275,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasGender  Male,0.206897,0.375,0.375,66,176,176,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Male,0.206897,0.5,0.5,66,132,132,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Male,0.137931,0.285714,0.285714,44,154,154,?a
?a  patientDrug  Gemcitabine   ,?a  hasGender  Male,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasGender  Male,0.310345,0.45,0.45,99,220,220,?a
?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.103448,0.375,0.375,33,88,88,?a
?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.241379,0.411765,0.411765,77,187,187,?a
?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.172414,0.384615,0.384615,55,143,143,?a
?a  hasStage  IV   ,?a  hasGender  Male,0.103448,0.375,0.375,33,88,88,?a
?a  patientDrug  Pemetrexed   ,?a  hasGender  Male,0.206897,0.352941,0.352941,66,187,187,?a
?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.241379,0.636364,0.636364,77,121,121,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Male,0.275862,0.533333,0.533333,88,165,165,?a
?a  hasAgeCategory  Old   ,?a  hasGender  Male,0.275862,0.615385,0.615385,88,143,143,?a
?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.103448,0.428571,0.428571,33,77,77,?a
?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.103448,0.375,0.375,33,88,88,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Male,0.206897,0.352941,0.352941,66,187,187,?a
?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.137931,0.5,0.5,44,88,88,?a
?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.206897,0.666667,0.666667,66,99,99,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.137931,0.444444,0.444444,44,99,99,?a
?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.413793,0.461538,0.461538,132,286,286,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.103448,0.25,0.25,33,132,132,?a
?a  hasStage  IVB   ,?a  hasGender  Male,0.103448,0.333333,0.333333,33,99,99,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.103448,0.272727,0.272727,33,121,121,?a
?a  hasStage  IVA   ,?a  hasGender  Male,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Young   ,?a  hasGender  Male,0.172414,0.3125,0.3125,55,176,176,?a
?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.413793,0.48,0.48,132,275,275,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.103448,0.375,0.375,33,88,88,?a
?a  type  Patient   ,?a  hasGender  Male,0.448276,0.448276,0.448276,143,319,319,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.37931,0.478261,0.478261,121,253,253,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.3125,0.3125,55,176,176,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  PDL1_Positive,0.147727,0.65,0.65,143,220,220,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.272727,0.272727,33,121,121,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.470588,0.470588,88,187,187,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.666667,0.666667,88,132,132,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.333333,0.333333,33,99,99,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.272727,0.272727,33,121,121,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.470588,0.470588,88,187,187,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.102273,0.692308,0.692308,99,143,143,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  PDL1_Positive,0.102273,0.5625,0.5625,99,176,176,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.384615,0.384615,55,143,143,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.555556,0.555556,55,99,99,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.555556,0.555556,55,99,99,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.583333,0.583333,77,132,132,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.113636,0.666667,0.666667,110,165,165,?a
?a  hasGender  Male   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.307692,0.307692,44,143,143,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Positive,0.136364,0.705882,0.705882,132,187,187,?a
?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.777778,0.777778,77,99,99,?a
?a  type  Patient   ,?a  hasBiomarker  PDL1_Positive,0.159091,0.482759,0.482759,154,319,319,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.625,0.625,55,88,88,?a
?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.113636,0.625,0.625,110,176,176,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.125,0.478261,0.478261,121,253,253,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.136364,0.461538,0.461538,132,286,286,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  PDL1_Positive,0.125,0.44,0.44,121,275,275,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.333333,0.333333,44,132,132,?a
?a  hasBiomarker  BRAF_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.75,0.75,33,44,44,?a
?a  patientDrug  Osimertinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.07,0.5,0.5,77,154,154,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.1,0.5,0.5,110,220,220,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.272727,0.272727,33,121,121,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.08,0.470588,0.470588,88,187,187,?a
?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.307692,0.307692,44,143,143,?a
?a  hasBiomarker  EGFR_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.08,0.5,0.5,88,176,176,?a
?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.5,0.5,44,88,88,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.375,0.375,33,88,88,?a
?a  patientDrug  Atezolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.428571,0.428571,33,77,77,?a
?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.5,0.5,44,88,88,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.08,0.470588,0.470588,88,187,187,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.08,0.470588,0.470588,88,187,187,?a
?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Bone,0.09,0.5625,0.5625,99,176,176,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.363636,0.363636,44,121,121,?a
?a  hasStage  IVB   ,?a  treatmentType  Radiotherapy_To_Bone,0.06,0.666667,0.666667,66,99,99,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.06,0.4,0.4,66,165,165,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Radiotherapy_To_Bone,0.07,0.4375,0.4375,77,176,176,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.333333,0.333333,33,99,99,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.1,0.4,0.4,110,275,275,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.625,0.625,55,88,88,?a
?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,1,1,88,88,88,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.09,1,1,99,99,99,?a
?a  patientDrug  Atezolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,1,1,77,77,77,?a
?a  hasGender  Male   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.230769,0.230769,33,143,143,?a
?a  type  Patient   ,?a  treatmentType  Radiotherapy_To_Bone,0.12,0.413793,0.413793,132,319,319,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.15,1,1,165,165,165,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.08,0.347826,0.347826,88,253,253,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.333333,0.333333,33,99,99,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.916667,0.916667,121,132,132,?a
?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,0.75,0.75,66,88,88,?a
?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,0.777778,0.777778,77,99,99,?a
?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,0.75,0.75,66,88,88,?a
?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.785714,0.785714,121,154,154,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,0.875,0.875,77,88,88,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.846154,0.846154,121,143,143,?a
?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.09,0.346154,0.346154,99,286,286,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.384615,0.384615,55,143,143,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,0.666667,0.666667,66,99,99,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,0.888889,0.888889,88,99,99,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.22,0.846154,0.846154,242,286,286,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,0.636364,0.636364,77,121,121,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.13,0.764706,0.764706,143,187,187,?a
?a  hasBiomarker  EGFR_Positive   ,?a  treatmentType  Intravenous_Chemotherapy,0.12,0.75,0.75,132,176,176,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,0.666667,0.666667,88,132,132,?a
?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.846154,0.846154,121,143,143,?a
?a  hasGender  Female   ,?a  treatmentType  Intravenous_Chemotherapy,0.12,0.75,0.75,132,176,176,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.1,0.909091,0.909091,110,121,121,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.15,0.882353,0.882353,165,187,187,?a
?a  type  Patient   ,?a  treatmentType  Intravenous_Chemotherapy,0.23,0.793103,0.793103,253,319,319,?a
?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.846154,0.846154,121,143,143,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.21,0.84,0.84,231,275,275,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.16,0.941176,0.941176,176,187,187,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Intravenous_Chemotherapy,0.12,0.75,0.75,132,176,176,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.17,0.85,0.85,187,220,220,?a
?a  patientDrug  Nivolumab   ,?a  type  Patient,0.275862,1,1,88,88,88,?a
?a  hasBiomarker  EGFR_Positive   ,?a  type  Patient,0.551724,1,1,176,176,176,?a
?a  patientDrug  Pembrolizumab   ,?a  type  Patient,0.448276,1,1,143,143,143,?a
?a  patientDrug  Docetaxel   ,?a  type  Patient,0.275862,1,1,88,88,88,?a
?a  hasBiomarker  EGFR_Negative   ,?a  type  Patient,0.413793,1,1,132,132,132,?a
?a  patientDrug  Paclitaxel   ,?a  type  Patient,0.310345,1,1,99,99,99,?a
?a  patientDrug  Atezolizumab   ,?a  type  Patient,0.241379,1,1,77,77,77,?a
?a  patientDrug  Vinorelbine   ,?a  type  Patient,0.275862,1,1,88,88,88,?a
?a  hasStage  IVB   ,?a  type  Patient,0.310345,1,1,99,99,99,?a
?a  hasStage  IVA   ,?a  type  Patient,0.206897,1,1,66,66,66,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  type  Patient,0.37931,1,1,121,121,121,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  type  Patient,0.517241,1,1,165,165,165,?a
?a  hasGender  Male   ,?a  type  Patient,0.448276,1,1,143,143,143,?a
?a  hasGender  Female   ,?a  type  Patient,0.551724,1,1,176,176,176,?a
?a  hasAgeCategory  Young   ,?a  type  Patient,0.551724,1,1,176,176,176,?a
?a  hasAgeCategory  Old   ,?a  type  Patient,0.448276,1,1,143,143,143,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  type  Patient,0.310345,1,1,99,99,99,?a
?a  treatmentType  Immunotherapy   ,?a  type  Patient,0.896552,1,1,286,286,286,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  type  Patient,0.275862,1,1,88,88,88,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  type  Patient,0.310345,1,1,99,99,99,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  type  Patient,0.413793,1,1,132,132,132,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  type  Patient,0.793103,1,1,253,253,253,?a
?a  hasRelapse_Progression  Progression   ,?a  type  Patient,0.862069,1,1,275,275,275,?a
?a  hasBiomarker  ROS1_Negative   ,?a  type  Patient,0.586207,1,1,187,187,187,?a
?a  hasBiomarker  ALK_Negative   ,?a  type  Patient,0.689655,1,1,220,220,220,?a
?a  patientDrug  Pemetrexed   ,?a  type  Patient,0.586207,1,1,187,187,187,?a
?a  hasBiomarker  PDL1_Positive   ,?a  type  Patient,0.482759,1,1,154,154,154,?a
?a  patientDrug  Carboplatin   ,?a  type  Patient,0.586207,1,1,187,187,187,?a
?a  patientDrug  Cisplatin   ,?a  type  Patient,0.37931,1,1,121,121,121,?a
?a  hasStage  IV   ,?a  type  Patient,0.275862,1,1,88,88,88,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Immunotherapy,0.12,1,1,132,132,132,?a
?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Immunotherapy,0.13,1,1,143,143,143,?a
?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.08,1,1,88,88,88,?a
?a  patientDrug  Docetaxel   ,?a  treatmentType  Immunotherapy,0.08,1,1,88,88,88,?a
?a  patientDrug  Atezolizumab   ,?a  treatmentType  Immunotherapy,0.07,1,1,77,77,77,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Immunotherapy,0.08,1,1,88,88,88,?a
?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Immunotherapy,0.12,0.857143,0.857143,132,154,154,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.16,0.941176,0.941176,176,187,187,?a
?a  hasStage  IV   ,?a  treatmentType  Immunotherapy,0.08,1,1,88,88,88,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.08,0.888889,0.888889,88,99,99,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.1,0.909091,0.909091,110,121,121,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Immunotherapy,0.13,1,1,143,143,143,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.24,0.96,0.96,264,275,275,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Immunotherapy,0.09,1,1,99,99,99,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Immunotherapy,0.17,0.85,0.85,187,220,220,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Immunotherapy,0.15,0.882353,0.882353,165,187,187,?a
?a  hasBiomarker  EGFR_Positive   ,?a  treatmentType  Immunotherapy,0.13,0.8125,0.8125,143,176,176,?a
?a  hasStage  IVB   ,?a  treatmentType  Immunotherapy,0.07,0.777778,0.777778,77,99,99,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.1,0.909091,0.909091,110,121,121,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.16,0.941176,0.941176,176,187,187,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Immunotherapy,0.13,0.8125,0.8125,143,176,176,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Immunotherapy,0.09,0.75,0.75,99,132,132,?a
?a  hasGender  Male   ,?a  treatmentType  Immunotherapy,0.12,0.923077,0.923077,132,143,143,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.14,0.933333,0.933333,154,165,165,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.22,0.956522,0.956522,242,253,253,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.08,0.888889,0.888889,88,99,99,?a
?a  hasGender  Female   ,?a  treatmentType  Immunotherapy,0.14,0.875,0.875,154,176,176,?a
?a  type  Patient   ,?a  treatmentType  Immunotherapy,0.26,0.896552,0.896552,286,319,319,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasStage  IVA  ?a  patientDrug  Afatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Osimertinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Lorlatinib  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IIIA  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Emibetuzumab  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Osimertinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Afatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Emibetuzumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasStage  IIIA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.625,0.625,55,88,88,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.5,0.5,22,44,44,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.137931,1,1,44,44,44,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.25,0.25,11,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Other   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.333333,0.333333,22,66,66,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.428571,0.428571,33,77,77,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.3125,0.3125,55,176,176,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Female   ,?a  hasSmokingHabit  FormerSmoker,0.206897,0.6,0.6,66,110,110,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasStage  IIIA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.571429,0.571429,44,77,77,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Emibetuzumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasSmokingHabit  FormerSmoker,0.206897,0.545455,0.545455,66,121,121,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.5,0.5,44,88,88,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.5,0.5,22,44,44,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Afatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.241379,0.538462,0.538462,77,143,143,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nintedanib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Daratumumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.5,0.5,44,88,88,?a
?a  hasGender  Female  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Emibetuzumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.4,0.4,44,110,110,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Young  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.571429,0.571429,44,77,77,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.172414,0.454545,0.454545,55,121,121,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.206897,0.6,0.6,66,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nintedanib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Daratumumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Daratumumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.5,0.5,22,44,44,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Osimertinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  patientDrug  Other  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasStage  IVB  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.241379,0.538462,0.538462,77,143,143,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.241379,0.4375,0.4375,77,176,176,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.241379,0.538462,0.538462,77,143,143,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Lorlatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.206897,0.75,0.75,66,88,88,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  hasAgeCategory  Young,0.103448,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Young,0.103448,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.206897,0.6,0.6,66,110,110,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.275862,0.727273,0.727273,88,121,121,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.172414,0.625,0.625,55,88,88,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Lorlatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Brigatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Emibetuzumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Alectinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Nintedanib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Daratumumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Other   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Brigatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Osimertinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Alectinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Young,0.310345,0.75,0.75,99,132,132,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Lorlatinib  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.172414,1,1,55,55,55,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.344828,0.416667,0.416667,110,264,264,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasStage  IIIB  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Other  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.5,0.5,22,44,44,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.4,0.4,22,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.275862,0.615385,0.615385,88,143,143,?a
?a  hasStage  IV  ?a  patientDrug  Erlotinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.172414,1,1,55,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Lorlatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Young,0.206897,0.666667,0.666667,66,99,99,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.172414,1,1,55,55,55,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Young,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Other   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.241379,0.7,0.7,77,110,110,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.206897,1,1,66,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.172414,0.625,0.625,55,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Other   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.172414,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasStage  IVB  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.137931,1,1,44,44,44,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.206897,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nintedanib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVA   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.172414,1,1,55,55,55,?a
?a  patientDrug  Other  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasGender  Male  ?a  patientDrug  Afatinib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.241379,0.636364,0.636364,77,121,121,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.241379,0.538462,0.538462,77,143,143,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Young,0.310345,0.692308,0.692308,99,143,143,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.172414,0.625,0.625,55,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.241379,0.7,0.7,77,110,110,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Nintedanib   ,?a  hasSmokingHabit  FormerSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  patientDrug  Daratumumab   ,?a  hasSmokingHabit  FormerSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.275862,0.533333,0.533333,88,165,165,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasStage  IVB  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasAgeCategory  Young,0.103448,0.6,0.6,33,55,55,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.206897,0.6,0.6,66,110,110,?a
?a  patientDrug  Other  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.103448,0.5,0.5,33,66,66,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.310345,0.692308,0.692308,99,143,143,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.206897,0.666667,0.666667,66,99,99,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.172414,1,1,55,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.241379,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.172414,0.625,0.625,55,88,88,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Other  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.275862,0.615385,0.615385,88,143,143,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.413793,0.571429,0.571429,132,231,231,?a
?a  patientDrug  Other  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.206897,0.75,0.75,66,88,88,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  hasStage  IVB  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.137931,0.571429,0.571429,44,77,77,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.206897,0.857143,0.857143,66,77,77,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.137931,1,1,44,44,44,?a
?a  patientDrug  Other  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasGender  Female  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.172414,1,1,55,55,55,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Osimertinib  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasGender  Female  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.241379,1,1,77,77,77,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  ALK_Positive  ?a  hasGender  Male   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  MET_Negative  ?a  hasGender  Male   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  hasGender  Male   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.137931,0.8,0.8,44,55,55,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  patientDrug  Crizotinib   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Gemcitabine   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Young,0.206897,0.75,0.75,66,88,88,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasStage  IV  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.137931,1,1,44,44,44,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.137931,1,1,44,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.172414,1,1,55,55,55,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  KRAS_Negative  ?a  hasGender  Male   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.103448,0.75,0.75,33,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Old,0.034483,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IIIC   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.172414,0.833333,0.833333,55,66,66,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.103448,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Nintedanib   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Young,0.034483,1,1,11,11,11,?a
?a  hasGender  Male  ?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Young,0.034483,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.137931,0.444444,0.444444,44,99,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Relapse   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Young,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Old,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Old,0.206897,0.461538,0.461538,66,143,143,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.137931,0.5,0.5,44,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.137931,0.444444,0.444444,44,99,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIA   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  PDL1_Negative   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.172414,0.5,0.5,55,110,110,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.206897,0.6,0.6,66,110,110,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.137931,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Male   ,?a  hasAgeCategory  Old,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.241379,0.538462,0.538462,77,143,143,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasAgeCategory  Old,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Relapse   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.206897,0.5,0.5,66,132,132,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.068966,0.4,0.4,22,55,55,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Daratumumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Old,0.172414,0.555556,0.555556,55,99,99,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IIA  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.068966,0.5,0.5,22,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.137931,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.172414,0.625,0.625,55,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Old,0.137931,0.5,0.5,44,88,88,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IVA  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.137931,0.571429,0.571429,44,77,77,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Old,0.068966,0.5,0.5,22,44,44,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  hasAgeCategory  Old,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  hasStage  IIA  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  hasAgeCategory  Old,0.206897,0.666667,0.666667,66,99,99,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IVA  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.241379,0.538462,0.538462,77,143,143,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Old,0.103448,0.75,0.75,33,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.275862,0.666667,0.666667,88,132,132,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.137931,1,1,44,44,44,?a
?a  patientDrug  Gefitinib  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasStage  IIA  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.137931,0.571429,0.571429,44,77,77,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.172414,0.625,0.625,55,88,88,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.137931,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.034483,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasStage  IIIC  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IIA  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.344828,0.588235,0.588235,110,187,187,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.310345,0.529412,0.529412,99,187,187,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.137931,1,1,44,44,44,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.103448,1,1,33,33,33,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nintedanib   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.172414,0.5,0.5,55,110,110,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.137931,0.571429,0.571429,44,77,77,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.137931,1,1,44,44,44,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IV  ?a  patientDrug  Daratumumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.137931,0.5,0.5,44,88,88,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.103448,0.6,0.6,33,55,55,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Daratumumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Female   ,?a  hasAgeCategory  Old,0.034483,0.5,0.5,11,22,22,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  hasAgeCategory  Old,0.034483,0.333333,0.333333,11,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.344828,0.625,0.625,110,176,176,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasStage  IIIC   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasGender  Female  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.172414,0.555556,0.555556,55,99,99,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.137931,0.444444,0.444444,44,99,99,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.068966,0.5,0.5,22,44,44,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.172414,0.5,0.5,55,110,110,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.137931,0.5,0.5,44,88,88,?a
?a  hasStage  IV  ?a  patientDrug  Nintedanib   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasRelapse_Progression  Progression,0.214286,1,1,66,66,66,?a
?a  hasStage  IIIC  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.172414,0.625,0.625,55,88,88,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.034483,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.034483,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Old,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  Progression,0.285714,1,1,88,88,88,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIC  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.071429,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.214286,1,1,66,66,66,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.142857,1,1,44,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.142857,1,1,44,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  Progression,0.071429,0.666667,1,22,33,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.107143,1,1,33,33,33,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.02381,0.5,0.5,33,66,66,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.015873,0.5,0.5,22,44,44,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Lorlatinib  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Other   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Lorlatinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Brigatinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Alectinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Durvalumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVB  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  hasStage  IV   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Daratumumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Positive  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.015873,0.4,0.4,22,55,55,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.015873,0.5,0.5,22,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  MET_Negative  ?a  hasStage  IVB   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Lorlatinib  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  hasStage  IVB  ?a  patientDrug  Afatinib   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasStage  IVB  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Crizotinib  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIA  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.015873,0.5,0.5,22,44,44,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.015873,0.5,0.5,22,44,44,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.047619,0.545455,0.545455,66,121,121,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.015873,0.4,0.4,22,55,55,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IVB   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Osimertinib   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.02381,0.5,0.5,33,66,66,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  hasStage  IVB  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasStage  IVB  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Osimertinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  patientDrug  Cisplatin,0.02381,0.5,0.5,33,66,66,?a
?a  hasStage  IIA  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.031746,0.5,0.5,44,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.015873,0.5,0.5,22,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.02381,0.5,0.5,33,66,66,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.055556,0.583333,0.583333,77,132,132,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.055556,0.5,0.5,77,154,154,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  hasStage  IVB   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.031746,0.5,0.5,44,88,88,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.079365,0.47619,0.47619,110,231,231,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.015873,0.5,0.5,22,44,44,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  patientDrug  Crizotinib  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.031746,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Osimertinib  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.047619,0.461538,0.461538,66,143,143,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIA  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.02381,0.5,0.5,33,66,66,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.015873,0.5,0.5,22,44,44,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasGender  Female  ?a  patientDrug  Alectinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Positive  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasStage  IIA  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.031746,0.571429,0.571429,44,77,77,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasGender  Female  ?a  patientDrug  Brigatinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Lorlatinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasStage  IIIB   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.015873,0.4,0.4,22,55,55,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.02381,0.375,0.375,33,88,88,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Cisplatin,0.031746,0.4,0.4,44,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.02381,0.5,0.5,33,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.02381,0.375,0.375,33,88,88,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.031746,0.571429,0.571429,44,77,77,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Daratumumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIA  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.02381,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.015873,0.4,0.4,22,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.039683,0.625,0.625,55,88,88,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.031746,0.5,0.5,44,88,88,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Lorlatinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  RET_Negative   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.031746,0.571429,0.571429,44,77,77,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Brigatinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Alectinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.031746,0.4,0.4,44,110,110,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  patientDrug  Cisplatin,0.039683,0.555556,0.555556,55,99,99,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.015873,0.4,0.4,22,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Relapse   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIB   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.055556,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.031746,0.571429,0.571429,44,77,77,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.039683,0.555556,0.555556,55,99,99,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Durvalumab   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.02381,0.6,0.6,33,55,55,?a
?a  hasBiomarker  MET_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  patientDrug  Cisplatin,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  KRAS_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  patientDrug  Cisplatin,0.031746,0.8,0.8,44,55,55,?a
?a  hasGender  Male  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.015873,0.5,0.5,22,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Daratumumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IIIB   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  MET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Lorlatinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Brigatinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Alectinib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nintedanib  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Relapse   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Afatinib   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.031746,0.5,0.5,44,88,88,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.015873,0.4,0.4,22,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.02381,0.5,0.5,33,66,66,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIA   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  MET_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,0.5,0.5,11,22,22,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Crizotinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nintedanib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.047619,0.461538,0.461538,66,143,143,?a
?a  treatmentType  Thoracoscopy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Cisplatin,0.031746,0.571429,0.571429,44,77,77,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Daratumumab   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Relapse   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  patientDrug  Cisplatin,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Surgery   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.015873,0.4,0.4,22,55,55,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IIA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IIIB  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.047619,0.5,0.5,66,132,132,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIB   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.571429,0.571429,44,77,77,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.02381,0.5,0.5,33,66,66,?a
?a  hasGender  Male  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.310345,0.818182,0.818182,99,121,121,?a
?a  hasStage  IVB  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IV   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Other   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nintedanib   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.310345,0.75,0.75,99,132,132,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Nintedanib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.615385,0.615385,88,143,143,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.875,0.875,77,88,88,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.310345,0.9,0.9,99,110,110,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.344828,0.666667,0.666667,110,165,165,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasGender  Male  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.75,0.75,66,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.75,0.75,66,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.625,0.625,55,88,88,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.6,0.6,66,110,110,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.727273,0.727273,88,121,121,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,1,1,55,55,55,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Atezolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.344828,0.769231,0.769231,110,143,143,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IV   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.888889,0.888889,88,99,99,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.875,0.875,77,88,88,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IVA  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,1,1,44,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  hasStage  IVA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.37931,0.6875,0.6875,121,176,176,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.666667,0.666667,66,99,99,?a
?a  hasStage  IVB  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.448276,0.764706,0.764706,143,187,187,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.344828,0.714286,0.714286,110,154,154,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.875,0.875,77,88,88,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.37931,0.6875,0.6875,121,176,176,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.310345,0.818182,0.818182,99,121,121,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.310345,0.692308,0.692308,99,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.344828,0.769231,0.769231,110,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.241379,0.7,0.7,77,110,110,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.857143,0.857143,66,77,77,?a
?a  hasStage  IIA  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.413793,0.705882,0.705882,132,187,187,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,1,1,55,55,55,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.75,0.75,66,88,88,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,1,1,88,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.344828,0.833333,0.833333,110,132,132,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.344828,0.909091,0.909091,110,121,121,?a
?a  patientDrug  Other  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.571429,0.571429,88,154,154,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.545455,0.545455,66,121,121,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.666667,0.666667,66,99,99,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.625,0.625,55,88,88,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IIIC  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.6,0.6,66,110,110,?a
?a  hasBiomarker  MET_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasStage  IIA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.571429,0.571429,44,77,77,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.666667,0.666667,88,132,132,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,1,1,33,33,33,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.857143,0.857143,66,77,77,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.103448,0.75,0.75,33,44,44,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.275862,0.727273,0.727273,88,121,121,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,1,1,66,66,66,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.8,0.8,44,55,55,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.172414,0.555556,0.555556,55,99,99,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasStage  IIIC  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.75,0.75,66,88,88,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasStage  IIA  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.5,0.5,22,44,44,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  EGFR_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Daratumumab   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nintedanib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.137931,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Surgery   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.4,0.4,22,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  EGFR_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  treatmentType  Thoracoscopy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.045455,1,1,44,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  EGFR_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IIIC   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.206897,0.75,0.75,66,88,88,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Positive,0.090909,0.727273,0.727273,88,121,121,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.6,0.6,66,110,110,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.571429,0.571429,44,77,77,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Positive,0.056818,1,1,55,55,55,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Positive,0.102273,0.6,0.6,99,165,165,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.625,0.625,55,88,88,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVB  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasStage  IVB  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasStage  IIIA  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Positive,0.102273,0.6,0.6,99,165,165,?a
?a  patientDrug  Osimertinib  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Gefitinib   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Gefitinib  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Positive,0.045455,1,1,44,44,44,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IIIC  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Positive,0.045455,1,1,44,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Erlotinib   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Surgery   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Other  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Positive,0.045455,1,1,44,44,44,?a
?a  hasStage  IVA  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Female  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Positive,0.056818,1,1,55,55,55,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.545455,0.545455,66,121,121,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Female,0.172414,1,1,55,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.310345,0.75,0.75,99,132,132,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.241379,0.875,0.875,77,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasGender  Female,0.206897,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Female,0.241379,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Female,0.206897,0.545455,0.545455,66,121,121,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.275862,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.137931,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Positive,0.125,0.52381,0.52381,121,231,231,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.206897,0.75,0.75,66,88,88,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Osimertinib   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Female,0.344828,0.769231,0.769231,110,143,143,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.275862,0.727273,0.727273,88,121,121,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.241379,0.875,0.875,77,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.206897,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.206897,0.666667,0.666667,66,99,99,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.241379,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Other   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.344828,0.666667,0.666667,110,165,165,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVB  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IVA  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.206897,0.75,0.75,66,88,88,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.172414,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.37931,0.6875,0.6875,121,176,176,?a
?a  hasGender  Female  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IIIA  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.206897,0.75,0.75,66,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  hasGender  Female,0.206897,0.75,0.75,66,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.275862,0.8,0.8,88,110,110,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVA   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.137931,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Positive,0.079545,0.636364,0.636364,77,121,121,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.056818,1,1,55,55,55,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Female,0.206897,0.75,0.75,66,88,88,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Positive   ,?a  hasGender  Female,0.241379,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Positive,0.045455,1,1,44,44,44,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  EGFR_Positive,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Positive,0.068182,0.545455,0.545455,66,121,121,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Positive,0.022727,1,1,22,22,22,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.137931,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  EGFR_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Emibetuzumab  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Lorlatinib  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.172414,0.625,0.625,55,88,88,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.103448,0.6,0.6,33,55,55,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Lorlatinib   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.344828,0.625,0.625,110,176,176,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.206897,0.666667,0.666667,66,99,99,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.206897,0.75,0.75,66,88,88,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.206897,0.75,0.75,66,88,88,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.137931,1,1,44,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.241379,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Other  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Other   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.172414,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.344828,0.625,0.625,110,176,176,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasGender  Female,0.241379,0.7,0.7,77,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.103448,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Female,0.206897,1,1,66,66,66,?a
?a  hasStage  IIIC  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.137931,1,1,44,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.137931,1,1,44,44,44,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.310345,0.6,0.6,99,165,165,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.310345,0.692308,0.692308,99,143,143,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.137931,1,1,44,44,44,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.137931,0.571429,0.571429,44,77,77,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.137931,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Emibetuzumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.172414,1,1,55,55,55,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IV   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IV   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Lorlatinib   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Erlotinib   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.241379,0.875,0.875,77,88,88,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasGender  Female,0.172414,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.137931,1,1,44,44,44,?a
?a  patientDrug  Other  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.241379,0.777778,0.777778,77,99,99,?a
?a  hasStage  IV  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.103448,1,1,33,33,33,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.137931,1,1,44,44,44,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  hasGender  Female,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Brigatinib   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Emibetuzumab   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Alectinib   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.137931,0.571429,0.571429,44,77,77,?a
?a  hasStage  IV  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  hasStage  IV  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.103448,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.137931,0.8,0.8,44,55,55,?a
?a  hasStage  IVA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IIIA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.103448,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Other   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasGender  Female,0.034483,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Durvalumab   ,?a  hasGender  Female,0.034483,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasGender  Female,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.172414,0.625,0.625,55,88,88,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.37931,0.52381,0.52381,121,231,231,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.413793,0.545455,0.545455,132,242,242,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIC   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.103448,0.6,0.6,33,55,55,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.047619,0.666667,0.666667,66,99,99,?a
?a  hasStage  IIIC  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Surgery   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.068966,1,1,22,22,22,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Other   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Carboplatin,0.039683,0.625,0.625,55,88,88,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.448276,0.541667,0.541667,143,264,264,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IIIA  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.031746,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  patientDrug  Carboplatin,0.031746,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Other   ,?a  hasGender  Female,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.055556,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.055556,0.636364,0.636364,77,121,121,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  patientDrug  Carboplatin,0.055556,0.7,0.7,77,110,110,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.031746,1,1,44,44,44,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasStage  IIA  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasStage  IIIA  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.031746,1,1,44,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.039683,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Carboplatin,0.047619,0.75,0.75,66,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.071429,0.692308,0.692308,99,143,143,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVA   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Male   ,?a  patientDrug  Carboplatin,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.063492,0.666667,0.666667,88,132,132,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Positive   ,?a  patientDrug  Carboplatin,0.047619,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.071429,0.692308,0.692308,99,143,143,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.063492,0.888889,0.888889,88,99,99,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.063492,0.8,0.8,88,110,110,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.047619,0.75,0.75,66,88,88,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.039683,0.625,0.625,55,88,88,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.055556,0.875,0.875,77,88,88,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.031746,1,1,44,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.031746,1,1,44,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.095238,0.75,0.75,132,176,176,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Carboplatin,0.031746,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.079365,0.769231,0.769231,110,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  patientDrug  Carboplatin,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.103175,0.764706,0.764706,143,187,187,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.055556,0.875,0.875,77,88,88,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.031746,1,1,44,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.039683,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.079365,0.769231,0.769231,110,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.039683,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Carboplatin,0.063492,0.8,0.8,88,110,110,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.071429,0.75,0.75,99,132,132,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.103175,0.764706,0.764706,143,187,187,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.071429,0.692308,0.692308,99,143,143,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.047619,0.75,0.75,66,88,88,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Carboplatin,0.047619,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  hasStage  IVB  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasGender  Male  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  patientDrug  Carboplatin,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.039683,1,1,55,55,55,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.087302,0.733333,0.733333,121,165,165,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.007937,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.047619,0.857143,0.857143,66,77,77,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIA   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.047619,0.857143,0.857143,66,77,77,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  patientDrug  Carboplatin,0.02381,1,1,33,33,33,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.079365,0.714286,0.714286,110,154,154,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.031746,0.8,0.8,44,55,55,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  patientDrug  Carboplatin,0.039683,1,1,55,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.039683,1,1,55,55,55,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Other   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.071429,0.692308,0.692308,99,143,143,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.063492,0.8,0.8,88,110,110,?a
?a  patientDrug  Other  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.047619,0.75,0.75,66,88,88,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.079365,0.833333,0.833333,110,132,132,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  treatmentType  Thoracoscopy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Durvalumab   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.055556,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.071429,0.818182,0.818182,99,121,121,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Lorlatinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasStage  IIA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Crizotinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.007937,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.015873,0.5,0.5,22,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.047619,0.857143,0.857143,66,77,77,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.015873,0.5,0.5,22,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pembrolizumab,0.071429,0.818182,0.818182,99,121,121,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.015873,1,1,22,22,22,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.047619,0.75,0.75,66,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IIIB   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pembrolizumab,0.015873,0.5,0.5,22,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,0.333333,0.333333,11,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.015873,0.5,0.5,22,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  patientDrug  Pembrolizumab,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IVA   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Positive  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasStage  IIA  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Pembrolizumab,0.047619,0.545455,0.545455,66,121,121,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.055556,0.875,0.875,77,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVA   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Pembrolizumab,0.039683,0.555556,0.555556,55,99,99,?a
?a  hasStage  IVA  ?a  patientDrug  Afatinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Lorlatinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Alectinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Afatinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  patientDrug  Pembrolizumab,0.02381,1,1,33,33,33,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  patientDrug  Pembrolizumab,0.02381,0.75,0.75,33,44,44,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.02381,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Pembrolizumab,0.047619,0.75,0.75,66,88,88,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.02381,0.75,0.75,33,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Pembrolizumab,0.055556,0.636364,0.636364,77,121,121,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Other   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Pembrolizumab,0.047619,0.666667,0.666667,66,99,99,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.031746,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  patientDrug  Pembrolizumab,0.047619,0.545455,0.545455,66,121,121,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.02381,0.5,0.5,33,66,66,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pembrolizumab,0.071429,0.818182,0.818182,99,121,121,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Pembrolizumab,0.015873,0.5,0.5,22,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  patientDrug  Pembrolizumab,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.063492,0.571429,0.571429,88,154,154,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pembrolizumab,0.031746,0.571429,0.571429,44,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pembrolizumab,0.063492,0.615385,0.615385,88,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pembrolizumab,0.071429,0.5625,0.5625,99,176,176,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.071429,0.75,0.75,99,132,132,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Brigatinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pembrolizumab,0.02381,0.6,0.6,33,55,55,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pembrolizumab,0.02381,0.6,0.6,33,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIB   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.071429,0.529412,0.529412,99,187,187,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.055556,0.875,0.875,77,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Other  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.02381,1,1,33,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.039683,0.625,0.625,55,88,88,?a
?a  hasStage  IIA  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.039683,0.625,0.625,55,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pembrolizumab,0.055556,0.7,0.7,77,110,110,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pembrolizumab,0.047619,0.6,0.6,66,110,110,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.055556,0.636364,0.636364,77,121,121,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pembrolizumab,0.02381,0.6,0.6,33,55,55,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pembrolizumab,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasStage  IIA  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.047619,0.545455,0.545455,66,121,121,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.02381,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pembrolizumab,0.063492,0.615385,0.615385,88,143,143,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  patientDrug  Pembrolizumab,0.031746,0.5,0.5,44,88,88,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.071429,0.529412,0.529412,99,187,187,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Pembrolizumab,0.047619,0.6,0.6,66,110,110,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.02381,0.6,0.6,33,55,55,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.063492,0.533333,0.533333,88,165,165,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pembrolizumab,0.063492,0.615385,0.615385,88,143,143,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pembrolizumab,0.063492,0.571429,0.571429,88,154,154,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.103175,0.541667,0.541667,143,264,264,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pembrolizumab,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.031746,0.571429,0.571429,44,77,77,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.031746,0.8,0.8,44,55,55,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pembrolizumab,0.063492,0.615385,0.615385,88,143,143,?a
?a  hasStage  IVB  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pembrolizumab,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pembrolizumab,0.031746,0.571429,0.571429,44,77,77,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.063492,0.571429,0.571429,88,154,154,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.02381,0.6,0.6,33,55,55,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Afatinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  patientDrug  Pembrolizumab,0.047619,0.545455,0.545455,66,121,121,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIA   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.055556,0.538462,0.538462,77,143,143,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.087302,0.52381,0.52381,121,231,231,?a
?a  hasStage  IVB  ?a  patientDrug  Other   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  patientDrug  Pembrolizumab,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.015873,0.5,0.5,22,44,44,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.063492,0.615385,0.615385,88,143,143,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pembrolizumab,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  treatmentType  Thoracoscopy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Relapse   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.063492,0.533333,0.533333,88,165,165,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.02381,0.5,0.5,33,66,66,?a
?a  hasGender  Male  ?a  patientDrug  Crizotinib   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Relapse   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  hasStage  IIA   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  hasStage  IIIB   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  hasSmokingHabit  NonSmoker   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pembrolizumab,0.015873,0.4,0.4,22,55,55,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIB   ,?a  patientDrug  Pembrolizumab,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  patientDrug  Pembrolizumab,0.047619,0.545455,0.545455,66,121,121,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.055556,0.583333,0.583333,77,132,132,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.031746,0.571429,0.571429,44,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.615385,0.615385,88,143,143,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.055556,0.583333,0.583333,77,132,132,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IIA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.727273,0.727273,88,121,121,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Other   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.02381,0.5,0.5,33,66,66,?a
?a  hasBiomarker  ALK_Positive  ?a  hasGender  Male   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.666667,0.666667,88,132,132,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasGender  Male  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.727273,0.727273,88,121,121,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pembrolizumab,0.063492,0.571429,0.571429,88,154,154,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.583333,0.583333,77,132,132,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.7,0.7,77,110,110,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Afatinib   ,?a  patientDrug  Pembrolizumab,0.007937,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pembrolizumab,0.015873,0.5,0.5,22,44,44,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pembrolizumab,0.063492,0.5,0.5,88,176,176,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pembrolizumab,0.031746,0.5,0.5,44,88,88,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pembrolizumab,0.031746,0.5,0.5,44,88,88,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.047619,0.6,0.6,66,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.625,0.625,55,88,88,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.555556,0.555556,55,99,99,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.113636,0.588235,0.588235,110,187,187,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Other   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasStage  IVB  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.625,0.625,55,88,88,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.102273,0.692308,0.692308,99,143,143,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.102273,0.5625,0.5625,99,176,176,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasGender  Male  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.113636,0.588235,0.588235,110,187,187,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pembrolizumab,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pembrolizumab,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  MET_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  KRAS_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.625,0.625,55,88,88,?a
?a  hasStage  IVB  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.4,0.4,22,55,55,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.461538,0.461538,66,143,143,?a
?a  hasStage  IVB  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.777778,0.777778,77,99,99,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.045455,1,1,44,44,44,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.5,0.5,22,44,44,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.625,0.625,55,88,88,?a
?a  hasGender  Male  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.5,0.5,66,132,132,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.6,0.6,66,110,110,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.045455,1,1,44,44,44,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.545455,0.545455,66,121,121,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.454545,0.454545,55,121,121,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.666667,0.666667,66,99,99,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.4,0.4,22,55,55,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasStage  IVB  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Crizotinib  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.5,0.5,22,44,44,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.545455,0.545455,66,121,121,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.4,0.4,22,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.444444,0.444444,44,99,99,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ALK_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasStage  IIA  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.5,0.5,77,154,154,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.5,0.5,66,132,132,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.615385,0.615385,88,143,143,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.102273,0.6,0.6,99,165,165,?a
?a  patientDrug  Other  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.615385,0.615385,88,143,143,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.5,0.5,44,88,88,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.727273,0.727273,88,121,121,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.538462,0.538462,77,143,143,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.045455,1,1,44,44,44,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.102273,0.642857,0.642857,99,154,154,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.079545,0.7,0.7,77,110,110,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  EGFR_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Other   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.4,0.4,22,55,55,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.4,0.4,22,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.6,0.6,66,110,110,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.125,0.5,0.5,121,242,242,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.090909,0.615385,0.615385,88,143,143,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.045455,1,1,44,44,44,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIA   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Lorlatinib  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasStage  IIA  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.056818,0.625,0.625,55,88,88,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IIA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Surgery   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.063492,0.8,0.8,88,110,110,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.063492,0.8,0.8,88,110,110,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.039683,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.055556,0.875,0.875,77,88,88,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Surgery   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.031746,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.087302,0.733333,0.733333,121,165,165,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.039683,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Osimertinib  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.007937,0.5,0.5,11,22,22,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Gefitinib  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasStage  IVB  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.047619,1,1,66,66,66,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.047619,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Lorlatinib   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Brigatinib   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasStage  IV  ?a  patientDrug  Alectinib   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Daratumumab   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  patientDrug  Pemetrexed,0.055556,0.7,0.7,77,110,110,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.047619,0.666667,0.666667,66,99,99,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.071429,0.692308,0.692308,99,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  patientDrug  Pemetrexed,0.047619,0.666667,0.666667,66,99,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Pemetrexed,0.055556,0.7,0.7,77,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.095238,0.705882,0.705882,132,187,187,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.031746,1,1,44,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.031746,1,1,44,44,44,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.055556,0.7,0.7,77,110,110,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.055556,0.875,0.875,77,88,88,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.047619,0.857143,0.857143,66,77,77,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasStage  IV  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.047619,0.75,0.75,66,88,88,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.047619,0.75,0.75,66,88,88,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.039683,0.625,0.625,55,88,88,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.047619,0.666667,0.666667,66,99,99,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.047619,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.055556,0.7,0.7,77,110,110,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Other   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.071429,0.692308,0.692308,99,143,143,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.103175,0.8125,0.8125,143,176,176,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.047619,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.055556,0.7,0.7,77,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.095238,0.705882,0.705882,132,187,187,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasStage  IVB  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  MET_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.055556,0.7,0.7,77,110,110,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.047619,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasStage  IIIA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.047619,0.666667,0.666667,66,99,99,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.039683,0.625,0.625,55,88,88,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Pemetrexed,0.055556,0.875,0.875,77,88,88,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.063492,0.8,0.8,88,110,110,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Positive   ,?a  patientDrug  Pemetrexed,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.031746,1,1,44,44,44,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.079365,0.769231,0.769231,110,143,143,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.047619,0.75,0.75,66,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  KRAS_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.02381,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.031746,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Pemetrexed,0.047619,0.75,0.75,66,88,88,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Pemetrexed,0.047619,0.666667,0.666667,66,99,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.039683,0.625,0.625,55,88,88,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Male   ,?a  patientDrug  Pemetrexed,0.031746,0.666667,0.666667,44,66,66,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.071429,0.692308,0.692308,99,143,143,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Pemetrexed,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.071429,0.75,0.75,99,132,132,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.039683,1,1,55,55,55,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.047619,0.75,0.75,66,88,88,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.079365,0.833333,0.833333,110,132,132,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.055556,0.875,0.875,77,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.087302,0.846154,0.846154,121,143,143,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.039683,0.714286,0.714286,55,77,77,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.087302,0.846154,0.846154,121,143,143,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.119048,0.714286,0.714286,165,231,231,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  patientDrug  Pemetrexed,0.039683,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Nintedanib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVA   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.031746,1,1,44,44,44,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.031746,0.666667,0.666667,44,66,66,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.055556,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.063492,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.071429,0.692308,0.692308,99,143,143,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  patientDrug  Other  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.063492,0.666667,0.666667,88,132,132,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.02381,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.039683,1,1,55,55,55,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.039683,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.063492,0.8,0.8,88,110,110,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  patientDrug  Pemetrexed,0.031746,0.666667,0.666667,44,66,66,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.031746,1,1,44,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasGender  Female  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.031746,1,1,44,44,44,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  hasGender  Male  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.02381,1,1,33,33,33,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Nintedanib   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  patientDrug  Pemetrexed,0.015873,0.5,0.5,22,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.031746,1,1,44,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Atezolizumab   ,?a  patientDrug  Pemetrexed,0.031746,1,1,44,44,44,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.087302,0.733333,0.733333,121,165,165,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.02381,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.02381,0.6,0.6,33,55,55,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.087302,0.785714,0.785714,121,154,154,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.090909,1,1,88,88,88,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.090909,1,1,88,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Other   ,?a  patientDrug  Pemetrexed,0.015873,1,1,22,22,22,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.056818,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.063492,0.666667,0.666667,88,132,132,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.031746,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.079545,1,1,77,77,77,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.102273,1,1,99,99,99,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.102273,1,1,99,99,99,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Pemetrexed,0.007937,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.079545,1,1,77,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.113636,0.909091,0.909091,110,121,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.125,1,1,121,121,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.147727,1,1,143,143,143,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.090909,1,1,88,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.136364,1,1,132,132,132,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.090909,1,1,88,88,88,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.102273,1,1,99,99,99,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.068182,1,1,66,66,66,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.113636,1,1,110,110,110,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.136364,0.8,0.8,132,165,165,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.125,1,1,121,121,121,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.090909,1,1,88,88,88,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.113636,0.909091,0.909091,110,121,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.068182,1,1,66,66,66,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.079545,1,1,77,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  patientDrug  Pemetrexed,0.015873,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasGender  Female  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.113636,1,1,110,110,110,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.113636,1,1,110,110,110,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.090909,1,1,88,88,88,?a
?a  hasStage  IIIC  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.079545,1,1,77,77,77,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  hasBiomarker  ALK_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  hasStage  IVA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.090909,1,1,88,88,88,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.068182,1,1,66,66,66,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.056818,1,1,55,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.102273,0.818182,0.818182,99,121,121,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Daratumumab   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  hasBiomarker  ALK_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.102273,0.818182,0.818182,99,121,121,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  ALK_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.034091,1,1,33,33,33,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.056818,1,1,55,55,55,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Positive   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasStage  IVA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.102273,0.75,0.75,99,132,132,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.5,0.5,33,66,66,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.136364,0.923077,0.923077,132,143,143,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.079545,1,1,77,77,77,?a
?a  hasStage  IVA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.102273,0.9,0.9,99,110,110,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.102273,1,1,99,99,99,?a
?a  hasStage  IVA  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.045455,1,1,44,44,44,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  patientDrug  Other  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.079545,0.875,0.875,77,88,88,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.056818,1,1,55,55,55,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.102273,0.9,0.9,99,110,110,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.056818,1,1,55,55,55,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.113636,0.909091,0.909091,110,121,121,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.079545,0.777778,0.777778,77,99,99,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.079545,0.7,0.7,77,110,110,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.125,0.6875,0.6875,121,176,176,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.113636,0.909091,0.909091,110,121,121,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  ROS1_Negative,0.102273,0.9,0.9,99,110,110,?a
?a  hasStage  IVB  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.045455,1,1,44,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.159091,0.823529,0.823529,154,187,187,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Alectinib  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.5,0.5,22,44,44,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.079545,0.636364,0.636364,77,121,121,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.5,0.5,22,44,44,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Lorlatinib   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.079545,0.777778,0.777778,77,99,99,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  ROS1_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  ROS1_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.5,0.5,22,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasGender  Male  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.666667,0.666667,66,99,99,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.068182,1,1,66,66,66,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.125,0.6875,0.6875,121,176,176,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  patientDrug  Gefitinib  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IIIC  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.045455,0.8,0.8,44,55,55,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Surgery   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  hasStage  IVB  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Surgery   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Lorlatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Brigatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Alectinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Placebo%20Controlled%20Study  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IIIC  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.079545,1,1,77,77,77,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.045455,1,1,44,44,44,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.625,0.625,55,88,88,?a
?a  patientDrug  Other  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.113636,0.714286,0.714286,110,154,154,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasGender  Female  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.75,0.75,66,88,88,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Alectinib   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.022727,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.147727,0.590909,0.590909,143,242,242,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Lorlatinib   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Brigatinib   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.011364,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.75,0.75,33,44,44,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.090909,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Male,0.137931,0.4,0.4,44,110,110,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVB   ,?a  hasGender  Male,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IV   ,?a  hasGender  Male,0.103448,0.5,0.5,33,66,66,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Other   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.103448,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Male,0.172414,0.555556,0.555556,55,99,99,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,1,1,33,33,33,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  KRAS_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  RET_Negative   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  ROS1_Negative,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  PDL1_Negative   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.103448,0.5,0.5,33,66,66,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.206897,0.545455,0.545455,66,121,121,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  hasGender  Male,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Relapse   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.137931,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.275862,0.470588,0.470588,88,187,187,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  MET_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Male,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Male,0.206897,0.461538,0.461538,66,143,143,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Afatinib   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.172414,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.068966,0.5,0.5,22,44,44,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.172414,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  hasGender  Male,0.068966,0.5,0.5,22,44,44,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.103448,0.5,0.5,33,66,66,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.275862,0.5,0.5,88,176,176,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Male,0.137931,0.363636,0.363636,44,121,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Male,0.068966,0.4,0.4,22,55,55,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Crizotinib  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Daratumumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Daratumumab  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.103448,0.75,0.75,33,44,44,?a
?a  hasStage  IIA  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasStage  IIA  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.103448,0.75,0.75,33,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.241379,0.7,0.7,77,110,110,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.103448,0.5,0.5,33,66,66,?a
?a  hasStage  IVB  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.172414,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.137931,0.8,0.8,44,55,55,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Male,0.103448,0.428571,0.428571,33,77,77,?a
?a  hasStage  IV  ?a  patientDrug  Durvalumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Other   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.206897,1,1,66,66,66,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Male,0.241379,0.538462,0.538462,77,143,143,?a
?a  hasStage  IVA  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.241379,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.103448,0.75,0.75,33,44,44,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.068966,0.5,0.5,22,44,44,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Durvalumab   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVB  ?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.137931,0.8,0.8,44,55,55,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  hasGender  Male,0.103448,1,1,33,33,33,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Gefitinib  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Crizotinib  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasStage  IIA  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.068966,0.4,0.4,22,55,55,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.068966,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.034483,0.333333,0.333333,11,33,33,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.034483,0.333333,0.333333,11,33,33,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  MET_Negative  ?a  hasStage  IVB   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.137931,0.8,0.8,44,55,55,?a
?a  hasStage  IVB  ?a  patientDrug  Osimertinib   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasStage  IVB  ?a  patientDrug  Afatinib   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasStage  IVB  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IVB   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  MET_Negative   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Daratumumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  hasStage  IVB   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IVB   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVA   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Erlotinib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Afatinib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IVA   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Gefitinib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.103448,0.75,0.75,33,44,44,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.103448,0.5,0.5,33,66,66,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  KRAS_Negative   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  RET_Negative   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Afatinib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  BRAF_Negative   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Osimertinib   ,?a  hasGender  Male,0.034483,0.333333,0.333333,11,33,33,?a
?a  patientDrug  Crizotinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  hasGender  Male,0.034483,0.333333,0.333333,11,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Afatinib   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Durvalumab   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Nintedanib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Crizotinib   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIB   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  hasGender  Male,0.137931,0.8,0.8,44,55,55,?a
?a  hasStage  IVA  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Positive   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.068966,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasGender  Male,0.034483,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IIIC   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.034483,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.333333,0.333333,22,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.777778,0.777778,77,99,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IV   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.333333,0.333333,11,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.777778,0.777778,77,99,99,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.045455,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.727273,0.727273,88,121,121,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  PDL1_Positive,0.102273,0.9,0.9,99,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.8,0.8,88,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  patientDrug  Other  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Positive,0.136364,0.75,0.75,132,176,176,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.888889,0.888889,88,99,99,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.113636,0.769231,0.769231,110,143,143,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.034091,1,1,33,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.113636,0.909091,0.909091,110,121,121,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  hasStage  IVB  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.034091,1,1,33,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Other   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.533333,0.533333,88,165,165,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.7,0.7,77,110,110,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.666667,0.666667,44,66,66,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.888889,0.888889,88,99,99,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.5,0.5,88,176,176,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.102273,0.9,0.9,99,110,110,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.102273,0.692308,0.692308,99,143,143,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.113636,0.714286,0.714286,110,154,154,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  KRAS_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.333333,0.333333,11,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.875,0.875,77,88,88,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.079545,1,1,77,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.875,0.875,77,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.056818,1,1,55,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.875,0.875,77,88,88,?a
?a  hasBiomarker  MET_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  RET_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.333333,0.333333,11,33,33,?a
?a  hasGender  Male  ?a  patientDrug  Nintedanib   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.714286,0.714286,55,77,77,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.102273,0.818182,0.818182,99,121,121,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Positive,0.102273,0.9,0.9,99,110,110,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.113636,0.769231,0.769231,110,143,143,?a
?a  hasGender  Male  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.875,0.875,77,88,88,?a
?a  hasGender  Male  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.333333,0.333333,11,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.7,0.7,77,110,110,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.583333,0.583333,77,132,132,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.5,0.5,88,176,176,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Durvalumab   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.75,0.75,33,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.045455,1,1,44,44,44,?a
?a  hasStage  IVA  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.045455,1,1,44,44,44,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.045455,1,1,44,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.727273,0.727273,88,121,121,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.034091,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.75,0.75,66,88,88,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.079545,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.625,0.625,55,88,88,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.714286,0.714286,55,77,77,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.5,0.5,88,176,176,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  PDL1_Positive,0.011364,0.5,0.5,11,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.571429,0.571429,44,77,77,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.034091,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  MET_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  KRAS_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Nintedanib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.045455,1,1,44,44,44,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.857143,0.857143,66,77,77,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.857143,0.857143,66,77,77,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.666667,0.666667,44,66,66,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIC   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IIIC  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVB  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.045455,1,1,44,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Atezolizumab   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.068182,1,1,66,66,66,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.090909,0.666667,0.666667,88,132,132,?a
?a  hasBiomarker  MET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.045455,0.8,0.8,44,55,55,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.034091,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  hasStage  IVA  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Afatinib   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.068182,0.666667,0.666667,66,99,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.363636,0.363636,44,121,121,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.6,0.6,33,55,55,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.056818,0.625,0.625,55,88,88,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.625,0.625,55,88,88,?a
?a  hasGender  Female  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  PDL1_Positive,0.022727,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Erlotinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  KRAS_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.125,0.5,0.5,121,242,242,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Bone,0.06,0.6,0.6,66,110,110,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.555556,0.555556,55,99,99,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.022727,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Atezolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.4,0.4,22,55,55,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.011364,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.06,0.6,0.6,66,110,110,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Afatinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVB   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,1,1,44,44,44,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.444444,0.444444,44,99,99,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Bone,0.06,0.6,0.6,66,110,110,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.555556,0.555556,55,99,99,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVA   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  BRAF_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,1,1,33,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.07,0.538462,0.538462,77,143,143,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Afatinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Radiotherapy_To_Bone,0.07,0.538462,0.538462,77,143,143,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.5,0.5,22,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Bone,0.07,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.5,0.5,33,66,66,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.06,0.6,0.6,66,110,110,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.6,0.6,33,55,55,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.555556,0.555556,55,99,99,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,1,1,44,44,44,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Other  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.5,0.5,22,44,44,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.4,0.4,22,55,55,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.6,0.6,33,55,55,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.75,0.75,33,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.714286,0.714286,55,77,77,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.625,0.625,55,88,88,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.5,0.5,44,88,88,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.6,0.6,33,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.6,0.6,33,55,55,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.5,0.5,44,88,88,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Surgery   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.5,0.5,33,66,66,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.07,0.636364,0.636364,77,121,121,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.363636,0.363636,44,121,121,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Surgery   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.75,0.75,33,44,44,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.75,0.75,33,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.6,0.6,33,55,55,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.5,0.5,55,110,110,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.8,0.8,44,55,55,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Surgery   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Atezolizumab  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Atezolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.5,0.5,22,44,44,?a
?a  patientDrug  Gefitinib  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Atezolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.5,0.5,22,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.4,0.4,22,55,55,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Emibetuzumab  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.6,0.6,33,55,55,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.08,0.533333,0.533333,88,165,165,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.6,0.6,33,55,55,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Atezolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Atezolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.75,0.75,33,44,44,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Surgery   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Emibetuzumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Erlotinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.8,0.8,44,55,55,?a
?a  hasStage  IV  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Atezolizumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.5,0.5,22,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.5,0.5,55,110,110,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Afatinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.5,0.5,22,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,0.75,0.75,33,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.8,0.8,44,55,55,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Erlotinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Emibetuzumab   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.4,0.4,22,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.4,0.4,22,55,55,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Erlotinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.5,0.5,44,88,88,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.04,0.571429,0.571429,44,77,77,?a
?a  hasGender  Male  ?a  patientDrug  Erlotinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IVB   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasStage  IVB  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.03,1,1,33,33,33,?a
?a  hasStage  IVA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.05,0.454545,0.454545,55,121,121,?a
?a  hasGender  Male  ?a  patientDrug  Afatinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.25,0.25,11,44,44,?a
?a  hasStage  IVB  ?a  patientDrug  Afatinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasStage  IVA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Emibetuzumab  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,1,1,88,88,88,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.1,1,1,110,110,110,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.06,0.461538,0.461538,66,143,143,?a
?a  hasGender  Male  ?a  patientDrug  Gefitinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasGender  Male  ?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,0.5,0.5,11,22,22,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,0.833333,0.833333,55,66,66,?a
?a  hasGender  Male  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,0.666667,0.666667,22,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Other   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,1,1,77,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,1,1,66,66,66,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,0.833333,0.833333,55,66,66,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Emibetuzumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,0.833333,0.833333,55,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,0.857143,0.857143,66,77,77,?a
?a  hasStage  IVB  ?a  patientDrug  Other   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasStage  IVB  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,0.888889,0.888889,88,99,99,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,0.875,0.875,77,88,88,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.916667,0.916667,121,132,132,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,0.8,0.8,44,55,55,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.1,0.833333,0.833333,110,132,132,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,1,1,88,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,1,1,88,88,88,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.1,0.909091,0.909091,110,121,121,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,0.8,0.8,88,110,110,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Surgery   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Durvalumab  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Other   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Gefitinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.02,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,1,1,66,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Erlotinib   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.01,1,1,11,11,11,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,1,1,66,66,66,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Other  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.13,0.866667,0.866667,143,165,165,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.16,0.941176,0.941176,176,187,187,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.12,0.857143,0.857143,132,154,154,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,0.8,0.8,44,55,55,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.09,1,1,99,99,99,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,0.875,0.875,77,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.846154,0.846154,121,143,143,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,0.875,0.875,77,88,88,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,0.857143,0.857143,66,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,0.888889,0.888889,88,99,99,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Positive   ,?a  treatmentType  Intravenous_Chemotherapy,0.06,0.857143,0.857143,66,77,77,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,1,1,88,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,1,1,77,77,77,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.09,0.9,0.9,99,110,110,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.09,0.9,0.9,99,110,110,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.04,1,1,44,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.846154,0.846154,121,143,143,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.12,0.857143,0.857143,132,154,154,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,0.875,0.875,77,88,88,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.1,0.909091,0.909091,110,121,121,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,1,1,77,77,77,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.15,0.9375,0.9375,165,176,176,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  treatmentType  Intravenous_Chemotherapy,0.01,1,1,11,11,11,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.11,0.846154,0.846154,121,143,143,?a
?a  patientDrug  Other  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.1,1,1,110,110,110,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.07,1,1,77,77,77,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  treatmentType  Intravenous_Chemotherapy,0.05,1,1,55,55,55,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.12,0.923077,0.923077,132,143,143,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.08,0.888889,0.888889,88,99,99,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.02,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.08,1,1,88,88,88,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.11,1,1,121,121,121,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.1,1,1,110,110,110,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.11,1,1,121,121,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.11,1,1,121,121,121,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Other   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.1,1,1,110,110,110,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.08,1,1,88,88,88,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.05,1,1,55,55,55,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.05,1,1,55,55,55,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.08,1,1,88,88,88,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.11,1,1,121,121,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.13,1,1,143,143,143,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.1,1,1,110,110,110,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  treatmentType  Immunotherapy,0.05,1,1,55,55,55,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.1,1,1,110,110,110,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.13,1,1,143,143,143,?a
?a  hasStage  IVB  ?a  patientDrug  Other   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.07,1,1,77,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  treatmentType  Immunotherapy,0.06,1,1,66,66,66,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  treatmentType  Immunotherapy,0.01,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.13,1,1,143,143,143,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.07,1,1,77,77,77,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.11,1,1,121,121,121,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Durvalumab   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.12,1,1,132,132,132,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.07,1,1,77,77,77,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.05,1,1,55,55,55,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.05,1,1,55,55,55,?a
?a  patientDrug  Other  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.02,1,1,22,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.03,1,1,33,33,33,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  treatmentType  Immunotherapy,0.04,1,1,44,44,44,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.06,1,1,66,66,66,?a
